• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NovaMed

NovaMed

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. V-Nova Ltd. Acquires Video Processing Patents from Faroudja Enterprises

    V- Nova Ltd. Acquires Video Processing Patents from Faroudja Enterprises

  2. Graves Diseases - Pipeline Review, H2 2016 - Key Companies are Apitope International NV, Nova Therapeutics LLC, Novartis AG, Omeros Corp & Rodos BioTarget GmbH - Research and Markets

    Graves Diseases - Pipeline Review, H2 2016 - Key Companies are Apitope International NV, Nova Therapeutics LLC, Novartis AG, Omeros Corp & Rodos BioTarget GmbH - Research and Markets

  3. Emera Reports 2016 Earnings and Significant Strategic Progress

    Emera Reports 2016 Earnings and Significant Strategic Progress

  4. Canada Factory Sales Post Surprise Surge in December

    Canada Factory Sales Post Surprise Surge in December

  5. Bank of Canada Official Says Multiple Core CPI Measures Best for Judging Rate Policy

    Bank of Canada Official Says Multiple Core CPI Measures Best for Judging Rate Policy

  6. Treasurys Retreat From Gains After Trump Says He Will Announce Tax Plan

    Treasurys Retreat From Gains After Trump Says He Will Announce Tax Plan

  7. TECO Peoples Gas Ranks Highest in Customer Satisfaction in Region in J.D. Power Study

    TECO Peoples Gas Ranks Highest in Customer Satisfaction in Region in J.D. Power Study

  8. Taubman Centers Announces the Amendment and Restatement of $1.1 Billion Line of Credit Including Additional $300 Million Unsecured Term Loan

    Taubman Centers Announces the Amendment and Restatement of $1.1 Billion Line of Credit Including Additional $300 Million Unsecured Term Loan

  9. Energy-Price Gain Leads Canada to Trade Surplus in December -- 2nd Update

    Energy-Price Gain Leads Canada to Trade Surplus in December -- 2nd Update

  10. Energy-Price Gain Leads Canada to Trade Surplus in December -- 2nd Update

    Energy-Price Gain Leads Canada to Trade Surplus in December -- 2nd Update

123

©2017 Morningstar Advisor. All right reserved.